<> Aarti Drugs Share Price Today: Live Aarti Drugs Share Price NSE/BSE | 5paisa
AARTIDRUGS

Aarti Drugs Share PriceAarti Drugs

₹419.25
17.05 (4.24%)
As on 04 February, 2023 | 07:35 BSE: 524348 NSE: AARTIDRUGS

Aarti Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Aarti Drugs

Start SIP

Aarti Drugs Share Price

  • Over 1 Month -6.81%
  • Over 3 Month -9.71%
  • Over 6 Month 0.34%
  • Over 1 Year -18.39%

Aarti Drugs Key Statistics

P/E Ratio 23.5
PEG Ratio -1.3
Market Cap Cr 3,882
Price to Book Ratio 3.7
EPS 21.1
Dividend 0.2
Relative Strength Index 43.53
Money Flow Index 56.84
MACD Signal -10.47
Average True Range 14.77

Aarti Drugs Investment Rating

  • Master Rating:
  • Aarti Drugs has an operating revenue of Rs. 2,667.91 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 11% is healthy, ROE of 19% is exceptional. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aarti Drugs Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 626625551641
Operating Expenses Qtr Cr 557555496557
Operating Profit Qtr Cr 69705584
Depreciation Qtr Cr 12121212
Interest Qtr Cr 9876
Tax Qtr Cr 12141014
Net Profit Qtr Cr 37372653

Aarti Drugs Technicals

EMA & SMA

Current Price
₹419.25
17.05 (4.24%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 423.72
  • 50 Day
  • 438.2
  • 100 Day
  • 445.23
  • 200 Day
  • 458.26
  • 20 Day
  • 427.9
  • 50 Day
  • 443.81
  • 100 Day
  • 453.67
  • 200 Day
  • 441.53

Aarti Drugs Resistance and Support

PIVOT
₹408.3
Resistance
First Resistance 415.6
Second Resistance 429
Third Resistance 436.3
RSI 43.53
MFI 56.84
MACD Single Line -10.47
MACD -11.71
Support
First Resistance 394.9
Second Resistance 387.6
Third Resistance 374.2

Aarti Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 246,361 5,390,379 21.88
Week 203,511 3,746,645 18.41
1 Month 96,871 2,754,036 28.43
6 Month 158,951 4,944,953 31.11

Aarti Drugs Result Highlights

Aarti Drugs Synopsis

NSE-Medical-Diversified

Aarti Drugs Ltd is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2251.17 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2022. Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433.
Market Cap 3,882
Sales 2,443
Shares in Float 3.70
No of funds 75
Yield 0.24
Book Value 3.99
U/D Vol ratio 0.9
LTDebt / Equity 12
Alpha -0.07
Beta 0.76

Aarti Drugs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 59.66%59.77%59.98%
Mutual Funds 3.82%3.08%2.68%
Insurance Companies 0.08%0.08%0.08%
Foreign Portfolio Investors 1.9%1.94%2.07%
Financial Institutions/ Banks
Individual Investors 25.98%26.66%32.16%
Others 8.56%8.47%3.03%

Aarti Drugs Management

Name Designation
Mr. Chandrakant V Gogri Chairman Emeritus
Mr. Prakash M Patil Chairman & M.D & CEO
Mr. Rashesh C Gogri Managing Director
Mr. Harshit M Savla Joint Managing Director
Mr. Harit P Shah Executive Director
Mr. Uday M Patil Executive Director
Mr. Neha R Gada Non Executive Director
CA. Navin C Shah Independent Director
Dr. Krishnacharya G Akamanchi Independent Director
Prof. Bhaskar N Thorat Independent Director
CA. Priti P Savla Independent Director

Aarti Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarti Drugs Corporate Action

Date Purpose Remarks
2023-01-27 Quarterly Results & Interim Dividend
2022-10-20 Quarterly Results
2022-07-27 Quarterly Results
2022-05-09 Audited Results
2022-01-31 Audited Results & Interim Dividend
Date Purpose Remarks
2023-02-08 INTERIM Rs.1.00 per share(10%)Interim Dividend
2022-02-10 INTERIM Rs.1.00 per share(10%)Interim Dividend

Aarti Drugs MF Shareholding

Name Amount(cr)
DSP Small Cap Fund Regular Plan Growth 9161
DSP Healthcare Fund Regular Growth 1228
DSP Value Fund Regular Plan Growth 578
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 397
Motilal Oswal Nifty 500 Fund Regular Growth 380

Aarti Drugs FAQs

What is Share Price of Aarti Drugs ?

Aarti Drugs share price is ₹419 As on 04 February, 2023 | 07:21

What is the Market Cap of Aarti Drugs ?

The Market Cap of Aarti Drugs is ₹3882.3 Cr As on 04 February, 2023 | 07:21

What is the P/E ratio of Aarti Drugs ?

The P/E ratio of Aarti Drugs is 23.5 As on 04 February, 2023 | 07:21

What is the PB ratio of Aarti Drugs ?

The PB ratio of Aarti Drugs is 3.7 As on 04 February, 2023 | 07:21

Q2FY23